Table 3 Comparison between clinical and serological features of SSc patients with and without joint erosions
| Â | Erosive arthropathy N = 24 (%) | Non erosive arthropathy N = 22 (%) | P* |
|---|---|---|---|
SSc subtype | Â | Â | Â |
   Diffuse SSc | 77,5 | 51,8 | 0,2 |
   Limited SSc | 22,5 | 48,2 | 0,3 |
Digital ulcers | 13 | 18 | 0,5 |
Calcinosis | 4 | 18 | 0,1 |
Organ involvement | Â | Â | Â |
   Lung disease | 58 | 50 | 0,5 |
   Kidney involvement | 4 | 4 | 1 |
   Heart involvement | 21 | 14 | 0,5 |
   Gastro-intestinal involvement | 32 | 42 | 0,9 |
Associated connectivitis | 21 | 30 | 0,4 |
   RA | 8 | 0 | 0,1 |
   SLE | 4 | 9 | 0,6 |
   Sjögren's Syndrome | 0 | 18 | 0,08 |
   Polymyositis | 8 | 5 | 0,4 |
Positive rheumatoid factor | 33 | 18 | 0,2 |
Positive antinuclear antibodies | 46 | 60 | 0,9 |
Anti topoisomerase I antibody | 4 | 5 | 0,9 |